Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for prevention of postoperative atrial fibrillation after elective cardiac surgery
ISRCTN15501019Phase 4Completed
- Sponsor
- Jordan Collaborative Cardiology Group
- Start
- Oct 2012
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of colchicine in Atrial fibrillation (AFib) (2 arms), sponsored by Jordan Collaborative Cardiology Group. Primary endpoints: Rate of atrial fibrillation and Occurrence of side effects. Started Oct 2012; status: completed.
02
Drugs
colchicine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on ISRCTN15501019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15501019.